Health Monitoring T cells may allow prevention of type 1 diabetes: Analyzing T cells in blood samples could… James Pereira Jul 23, 2023 Scripps Research scientists have shown that analyzing a certain type of immune cell in the blood can help identify… Read More...
Health Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) topical solution as the… James Pereira Jul 22, 2023 – Molluscum, is a highly contagious viral skin infection affecting approximately 6 million people annually in the… Read More...
Health ADC Therapeutics Announces Plan to Discontinue the Phase 2 LOTIS-9 Clinical Trial of ZYNLONTA®… James Pereira Jul 21, 2023 LAUSANNE, Switzerland, July 20, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that it… Read More...
Health Center for Disease Analysis Foundation Announces Receipt of an $8 Million Grant from Gilead… James Pereira Jul 20, 2023 LAFAYETTE, Colo., July 20, 2023 (GLOBE NEWSWIRE) -- The Center for Disease Analysis Foundation (CDA Foundation)… Read More...
Health NANOBIOTIX annonce qu’un premier patient a reçu une injection de NBTXR3 dans le cadre d’une nouvelle… James Pereira Jul 20, 2023 PARIS et CAMBRIDGE, Mass., 19 juill. 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO — NASDAQ : NBTX – la «… Read More...
Health NANOBIOTIX Announces First Patient Injected in New Phase 1/2 Study Evaluating Radiotherapy-Activated… James Pereira Jul 20, 2023 PARIS and CAMBRIDGE, Mass., July 19, 2023 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO — NASDAQ: NBTX – the… Read More...
Health Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia… James Pereira Jul 19, 2023 ST. LOUIS, July 18, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical… Read More...
Technology Apple Watch in India gets major life-saving update, heart patients can now monitor AFib history Kevin Colleran Jul 19, 2023 … Read More...
Health ASCO Urges Geriatric Assessments for Older Cancer Patients James Pereira Jul 18, 2023 Updated… Read More...
Health 4DMT Completes Enrollment of Phase 2 PRISM Clinical Trial for Intravitreal 4D-150 in Patients with… James Pereira Jul 18, 2023 Completed target enrollment of 50 patients in the randomized Phase 2 Dose Expansion stage of the PRISM clinical trial… Read More...